去年从$3.x 到了$6.X，收到FDA的CRL后，股价又回去了。
PSDV和ALIM的ILUVIEN NDA resubmission今天FDA Accepted， FDA decision by 11/12
/11
下半年还有European decision，MAA / EMA Decision (Europe)的门槛要比FDA低。
$23.7M cash / equivalents，sufficient to fund operations until 2013 短期内不
会发行新股了。
w****a 发帖数: 12
2
Thanks for sharing, will be go 20-30% up before Nov.
